A Study of Epetraborole Tablets in Subjects With Degrees of Renal Function

Summary

This is a Phase 1 study to evaluate the pharmacokinetics (PK), safety and tolerability of epetraborole tablets in adult subjects with normal renal function, subjects with various degrees of renal impairment, and subjects with end-stage renal disease (ESRD) receiving intermittent hemodialysis (IHD) therapy.

Timeline

Start

2022-02-21

Primary completion

2022-06-10

Completion

2022-06-27

Drugs

Indications